Detection of low frequency FGFR3 mutations in the urine of bladder cancer patients using next-generation deep sequencing

Biological fluid-based noninvasive biomarker assays for monitoring and diagnosing disease are clinically powerful. A major technical hurdle for developing these assays is the requirement of high analytical sensitivity so that biomarkers present at very low levels can be consistently detected. In the...

Descripción completa

Detalles Bibliográficos
Autores principales: Millholland, John M, Li, Shuqiang, Fernandez, Cecilia A, Shuber, Anthony P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806441/
https://www.ncbi.nlm.nih.gov/pubmed/24199178
http://dx.doi.org/10.2147/RRU.S32736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806441/
https://www.ncbi.nlm.nih.gov/pubmed/24199178
http://dx.doi.org/10.2147/RRU.S32736

Ejemplares similares